Compound Screening TRIZ Cases

Loop insertions in variant Fc-polypeptides increase neonatal Fc receptor binding at acidic pH, extending in vivo half-lives and reducing dosing frequency.

Single-molecule imaging quantifies GPCR diffusive dynamics on cell membranes to evaluate receptor activity.

Screening candidate substances by measuring Zip11 activity and expression levels to identify agents capable of modulating biological aging processes.

Resin beads with cleavable linkers attach living cells to test compounds for rapid physiological effect detection.

Glycoenzyme inhibitors target alpha-4GalT to modulate SSEA-3 synthesis, resolving poor marker selectivity for cancer stem cell enrichment.

Cannabinoids activate TRPV2 channels to enable selective ion flow measurement, resolving the lack of specific agonists in high-temperature screening systems.

Denaturing wash removes endotoxins from phagocytable particles, preventing background activation that masks low-level antigen-specific T-cell responses.

Site-directed mutations in the MGLL cap-domain eliminate detergent requirements during purification, enabling atomic-resolution X-ray diffraction.

A pseudoviral assay system measures infectivity levels using target cells expressing ACE-2 and nAChR receptors.

Detecting AGPAT9 and ANXA10 mRNA levels in EGF-cultured adipose stem cells provides objective quality control for therapeutic agents.

Amphiphilic molecules modulate biomolecular condensates to restore transcriptional activity, addressing functional interference from repeat expansion mutations.

Inhibiting complement activation prevents pathological synapse loss, maintaining neuronal connectivity to address early Alzheimer's disease damage.

CRISPR/Cas9 modifies Cdc20 translation start sites to enhance wild-type expression, preventing mitotic slippage and improving treatment efficacy.

Antibodies detect keratin degradation peptides for rapid periodontal disease diagnosis.

A tryptophanyl-tRNA synthetase inhibitor blocks myeloid-derived suppressor cell differentiation to enhance anticancer efficacy.

Specific probe compounds bind to Bruton's tyrosine kinase to quantify inhibitor occupancy in biological samples.

Segmenting signaling pathways using specific receptor profiles and ligand combinations reduces unwanted side effects from redundant interactions.

Flunarizine directs mitochondria into lysosomes for independent removal, avoiding nuclear instability caused by gene overexpression methods.

Dichlorofluorescein detects OATP1B1 transport activity via measurable fluorescence intensity changes.

Dynamic fluid flow mimics in vivo conditions, enabling accurate drug testing at physiologic concentrations.

Quantitative protein interaction analysis resolves genomic profiling gaps by measuring signal intensity to predict drug responsiveness.

Segmented biosensors enable high-resolution 3D imaging of cellular responses, overcoming limited resolution in traditional models.

Screen drug candidates by measuring calcium and phosphatidylinositol phosphate interaction using isothermal titration calorimetry.

A peptide composition inhibits OCT4 function to suppress cancer stem cell proliferation.

A scaffold-free three-dimensional pulmonary model tissue culture uses specific cell ratios and Wnt11 treatment to enhance ATII type differentiation.